1. Home
  2. SHOT vs PMN Comparison

SHOT vs PMN Comparison

Compare SHOT & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHOT
  • PMN
  • Stock Information
  • Founded
  • SHOT 2018
  • PMN 2004
  • Country
  • SHOT United States
  • PMN Canada
  • Employees
  • SHOT N/A
  • PMN N/A
  • Industry
  • SHOT Biotechnology: Pharmaceutical Preparations
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • SHOT Health Care
  • PMN Health Care
  • Exchange
  • SHOT Nasdaq
  • PMN Nasdaq
  • Market Cap
  • SHOT 31.4M
  • PMN 29.8M
  • IPO Year
  • SHOT 2020
  • PMN N/A
  • Fundamental
  • Price
  • SHOT $0.49
  • PMN $0.95
  • Analyst Decision
  • SHOT
  • PMN
  • Analyst Count
  • SHOT 0
  • PMN 0
  • Target Price
  • SHOT N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • SHOT 667.9K
  • PMN 42.4K
  • Earning Date
  • SHOT 03-31-2025
  • PMN 03-31-2025
  • Dividend Yield
  • SHOT N/A
  • PMN N/A
  • EPS Growth
  • SHOT N/A
  • PMN N/A
  • EPS
  • SHOT N/A
  • PMN N/A
  • Revenue
  • SHOT $652,495.00
  • PMN N/A
  • Revenue This Year
  • SHOT N/A
  • PMN N/A
  • Revenue Next Year
  • SHOT N/A
  • PMN N/A
  • P/E Ratio
  • SHOT N/A
  • PMN N/A
  • Revenue Growth
  • SHOT 68.01
  • PMN N/A
  • 52 Week Low
  • SHOT $0.45
  • PMN $0.87
  • 52 Week High
  • SHOT $2.89
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • SHOT 41.03
  • PMN 52.16
  • Support Level
  • SHOT $0.46
  • PMN $0.88
  • Resistance Level
  • SHOT $0.48
  • PMN $1.03
  • Average True Range (ATR)
  • SHOT 0.04
  • PMN 0.06
  • MACD
  • SHOT 0.01
  • PMN 0.00
  • Stochastic Oscillator
  • SHOT 28.35
  • PMN 46.67

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: